Lessons from elective in vitro fertilization (IVF) in, principally, non-infertile women

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Gleicher, Norbert ^a,b   Kim, Ann ^a   Weghofer, Andrea ^a,c   Barad, David H ^a,b  

^a CENTER FOR HUMAN REPRODUCTION   (United States)

^b Foundation for Reproductive Medicine   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aneuploidy; Anti M llerian hormone (AMH); Gonadotropin dosage; In vitro fertilization (IVF); Pregnancy rates; Preimplantation genetic diagnosis (PGD); Preimplantation genetic screening (PGS); Single embryo transfer

Indexed keywords

FOLLITROPIN; GONADOTROPIN; LEUPRORELIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SCREENING; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE INFERTILITY; PATIENT SELECTION; PLOIDY; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PREIMPLANTATION GENETIC SCREENING; SEXUAL SELECTION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; ANTI-MULLERIAN HORMONE; EMBRYO TRANSFER; EMBRYO, MAMMALIAN; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; INFERTILITY; INFERTILITY, FEMALE; MALE; MENOTROPINS; PLOIDIES; PREGNANCY; PREGNANCY RATE; PREIMPLANTATION DIAGNOSIS; SEX PRESELECTION; SINGLE EMBRYO TRANSFER; TREATMENT OUTCOME;

EID: 84862321258     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-48     Document Type: Article

References (44)

1. Fritz MA, Speroff L. Section IV, Infertility. Clinical Gynecology and Infertility 2011, Philadephia, PA: Lippincott Williams & Wilkins, a Wolters Kluwer business, 8.
2. Munné S, Howles CM, Wells D. The role of preimplantation genetic diagnosis in diagnosing embryo aneuploidy. Curr Opin Obstet Gynecol 2009, 21:442-449. 10.1097/GCO.0b013e32832fad73, 19606031.
3. National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health 2009 Assisted Reproductive Technology Success rates December 2010, US: Atlanta, GA: Department of Health and Human Services, Center for Disease Control and Prevention, National Summary and Fertility Clinic Reports, US, National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health.
4. Gianaroli L, Magli MC, Fiorentino F, Baldi M, Ferraretti AP. Clinical value of preimplantation genetic diagnosis. Placenta 2003, 24(SupplB):S77-S83.
5. Donoso P, Staessen C, Fauser BC, Devroey P. Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update 2007, 13:15-25.
6. Practice Committees Society for Assisted Reproductive Technologies and American Society for Reproductive Medicine Preimplantation genetic testing; a Practice Committee opinion. Fertil Steril 2008, 90:S136-S143. Practice Committees Society for Assisted Reproductive Technologies and American Society for Reproductive Medicine.
7. Anderson RA, Pickering S. The current status of preimplantation genetic screening: British Fertility Society Policy and Practice Guidelines. Hum Fertil (Camb) 2008, 11:71-75.
8. Mastenbroeks S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update 2011, 17:454-466. 10.1093/humupd/dmr003, 21531751.
9. Robertson JA. View of the ASRM Ethics Committee. Hum Reprod 2003, 18:464. 10.1093/humrep/deg064, 12571198.
10. Ethics Committee of the American Society of Reproductive Medicine Preconception gender selection for nonmedical reasons. Fertil Steril 2004, 82(Suppl 1):S232-S235. Ethics Committee of the American Society of Reproductive Medicine.
11. Barad DH, Weghofer A, Gleicher N. Age-specific levels of basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007, 109:1404-1410. 10.1097/01.AOG.0000264065.37661.a0, 17540814.
12. Barad DH, Weghofer A, Gleicher N. Utility of age-specific serum anti-Müllerian hormone concentration. Reprod Biomed Online 2011, 22:284-291. 10.1016/j.rbmo.2010.12.002, 21269880.
13. Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: " established" and ready for prime time?. Fertil Steril 2008, 89:780-789. 10.1016/j.fertnstert.2008.01.072, 18353323.
14. Pal L, Santoro N. Age-related decline in fertility. Endocrinol Metabol Clin North Am 2003, 32:669-688.
15. Hardarson T, Hanson C, Lundin K, Hillensjö T, Nilsson L, Stevic J, Reismer E, Borg K, Wikland M, Bergh C. Preimplantation genetic screening in women with advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 2008, 23:2806-2812. 10.1093/humrep/den217, 18583331.
16. Cohen J, Wells D, Munné S. Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 2007, 87:496-503. 10.1016/j.fertnstert.2006.07.1516, 17141767.
17. Gleicher N, Barad D. Twin pregnancy, contrary to consensus, is a desirable outcome in infertility. Fertil Steril 2009, 91:2426-2431. 10.1016/j.fertnstert.2008.02.160, 18439598.
18. Pandian Z, Bhattacharya S, Ozturk O, Serour G, Templeton A. Number of embryos for transfer following in-vitro fertilization or intra-cytopalsmic sperm injection. Cochrane Database Syst Rev 2009, 15(2):CD003416.
19. Lie Fong S, Baart EB, Martini E, Schipper I, Visser JA, Themmen AP, de Jong FH, Fauser BJ, Laven JS. Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality?. Reprod Biomed Online 2008, 16:664-670. 10.1016/S1472-6483(10)60480-4, 18492370.
20. Gleicher N, Kim A, Weghofer A, Barad DH. Toward a better understanding of functional ovarian reserve: AMH (AMHo) and FSH (FSHo) hormone ratios per retrieved oocyte. J Clin Endocrinol Metab 2012, 97:995-1004. 10.1210/jc.2011-2403, 22170712.
21. Gleicher N, Weghofer A. Oocyte yields per anti-Müllerian hormone (AMH) at different female ages change with advancing female age: A new tool to assess oocyte quality?. Fertil Steril 2011, 96(Suppl):S281.
22. Weghofer A. Asian women demonstrate diminished functional ovarian reserve, defined by anti-Müllerian hormone (AMH) and oocyte yields. Fertil Steril 2011, 96(Suppl):S80-S81.
23. Gleicher N, Weghofer A, Barad DH. Improvement in diminished ovarian reserve after dehydroepiandrosterone supplementation. Reprod Biomed Online 2010, 21:360-365. 10.1016/j.rbmo.2010.04.006, 20638339.
24. Gleicher N, Weghofer A, Barad DH. Dehydroepiandrosterone (DHEA) reduces embryo aneuploidy: direct evidence from preimplantation genetic screening (PGS). Reprod Biol Endocrinol 2010, 8:140. 10.1186/1477-7827-8-140, 2992540, 21067609.
25. Gleicher N, Ryan E, Weghofer A, Blanco-Meija S, Barad DH. Miscarriage rates after dehydroepiandrosterone (DHEA) supplementation in women with diminished ovarian reserve: a case control study. Reprod Biol Endocrinol 2009, 7:108. 10.1186/1477-7827-7-108, 2764711, 19811650.
26. Barad DH, Gleicher N. Increased oocyte production after treatment with dehydroepiandrosterone. Fertil Steril 2005, 84:756.
27. Barad D, Gleicher N. Effect of dehydroepiandrosterone on oocyte and embryo yields, embryo grade and cell number in IVF. Hum Reprod 2006, 21:2845-2849. 10.1093/humrep/del254, 16997936.
28. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet 2007, 24:629-634. 10.1007/s10815-007-9178-x, 18071895.
29. Baart EB, Martini E, Eikemans MJ, van Opstal D, Beckers NG, Verhoeff A, Macklon NS, Fauser BC. Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial. Hum Reprod 2007, 22:980-988. 10.1093/humrep/del484, 17204525.
30. Xu YW, Peng YT, Wang B, Zeng YH, Zhuang GL, Zhou CQ. High follicle-stimulating hormone increases aneuploidy in human oocytes matured in vitro. Fertil Steril 2011, 95:99-104. 10.1016/j.fertnstert.2010.04.037, 20553786.
31. Siristadtidis CS, Hamilton MP. What should be the maximum FSH dose in IVF/ICSI in poor responders?. J Obstet Gynecol 2007, 27:401-405.
32. Massie JA, Shahine LK, Mikki AA, Westphal LM, Lathi RB. Ovarian stimulation and the risk of aneuploidy conceptions. Fertil Steril 2011, 95:970-972. 10.1016/j.fertnstert.2010.07.1088, 20828683.
33. Weghofer A, Munné S, Brannath W, Chen S, Tomkin G, Cekleniak N, Garrisi M, Barad D, Cohen J, Gleicher N. The impact of LH-containing gonadotropins on diploidy rates in preimplantation embryos: long protocol stimulation. Hum Reprod 2008, 23:499-503. 10.1093/humrep/dem412, 18182396.
34. Li M, Schatten H, Sun Q-Y. Androgen receptor's destiny in mammalian oocytes: a new hypothesis. Molec Hum Reprod 2009, 15:149-154. 10.1093/molehr/gap006, 19193657.
35. Young JM, McNeilly AS. Theca: the forgotten cell of the ovarian follicle. Reproduction 2010, 140:489-504. 10.1530/REP-10-0094, 20628033.
36. Sen A, Hammer SR. Granulosa-cell specific androgen receptors are critical regulators of ovarian development and function. Mol Endocrinol 2010, 24:1393-1403. 10.1210/me.2010-0006, 2903904, 20501640.
37. Gleicher N, Weghofer A, Barad DH. The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?. Reprod Biol Endocrinol 2011, 9:116. 10.1186/1477-7827-9-116, 3170254, 21849061.
38. Kuliev A, Verlinsky Y. The role of preimplantation genetic diagnosis in women of advanced reproductive age. Curr Opin Obstet Gynecol 2003, 15:233-238. 10.1097/00001703-200306000-00004, 12858111.
39. Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyt PM, et al. In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007, 357:9-17. 10.1056/NEJMoa067744, 17611204.
40. Gutiérerez-Mateo C, Colls P, Sánchez-Garcia J, Escudero T, Prates R, Ketterson K, Wells D, Munné S. Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011, 95:953-958. 10.1016/j.fertnstert.2010.09.010, 20971462.
41. Gleicher N, Barad D. Misplaced obsession with prospectively randomized studies. Reprod Biomed Online 2010, 21:440-443. 10.1016/j.rbmo.2010.06.042, 20800545.
42. Martinez MC, Méndez C, Ferro J, Nicolás M, Serra V, Landeras J. Cytogenetic analysis of early nonviable pregnancies after assisted reproduction treatment. Fertil Steril 2010, 93:289-292. 10.1016/j.fertnstert.2009.07.989, 19748088.
43. Brandes M, Verzijden JC, Hamilton CJ, de Weys NP, de Bruin JP, Bots RS, Nelen WL, Kremer JA. Is the fertility treatment itself a risk factor for early pregnancy loss?. Reprod Biomed Online 2011, 22:192-199. 10.1016/j.rbmo.2010.10.013, 21195668.
44. Harper J, Coonen E, De Rycke M, Fiorentino F, Geraedts J, Goosens V, Harton G, Moutou C, Pehlivan Budas T, Renwick P, et al. What next for preimplantation genetic screening (PGS)? A position statement from the ESHRE PGD Consortium Steering Committee. Hum Reprod 2010, 25:821-823. 10.1093/humrep/dep476, 20124394.